To ensure diversity and independence of Board members, directors shall be elected pursuant to the candidates nomination system in accordance with TSH Biopharm’s “Articles of Incorporation”, “Procedures for Election of Directors” and “Corporate Governance Best-Practice Principles”.
The Company's Board of Directors is currently set up with seven directors, three of which are independent directors.
The term of office of the current Board of Directors is from May 29, 2020 to May 28, 2023.
Wang, Yi-Min, the former independent director of the Company, resigned on April 15, 2022. The by-election was held in the General Shareholders’ Meeting on May 25, 2022, and Huang, Yaw-Bin has been elected.
Current Position(s): Chairman, TTY Biopharm Company Limited
Ph.D., Economics, University of Illinois at Urbana-Champaign, USA
Director, TTY Biopharm Company Limited
Director, Dawan Technology Co., Ltd.
Director, American Taiwan Biopharm Co., Ltd.
PharmD, University of the Pacific Thomas J Long School of Pharmacy MBA, University of the Pacific Eberhardt School of Business
Remuneration Committee Member, Pharma Engine
Bachelor’s Degree, Economics, Tung Hai University MA in Economics, University of Memphis
Chairman and CEO, IROC Co., Ltd.
Independent Director, CCP Contact Probes Co., Ltd.
Independent Director, Radium Construction Co., Ltd.
Independent Director, Orient Pharma Co., Ltd.
Director, Taichung Bank Securities Co., Ltd.
Director, Chang Wah Electromaterials Inc.
Director, Super Dragon Technology Company Limited.
Director, ATrack Technology Inc.
Director, JMC Electronics Co., Ltd.
International MBA, University of St. Thomas, Minnesota State, USA
Partner, Moores Rowland CPAs
Independent Director, Pharma Engine
Bachelor’s Degree in Accounting, Soochow University
Dean of Kaohsiung Medical University
Professor of Pharmacy Kaohsiung Medical University
Chief Pharmacist of Kaohsiung Medical University Chung-Ho Memorial Hospital
PhD in Pharmacy, School of Pharmacy, Kaohsiung Medical University
MS in Pharmacy, School of Pharmacy, Kaohsiung Medical University
BS in Pharmacy, School of Pharmacy, Kaohsiung Medical University
Independent Director, Welgene Biotech Co., Ltd.
MBA, Columbia Business School, USA
Bachelor’s Degree in Biology, National Taiwan Normal University
According to Article 20 of the Company’s “Corporate Governance Best-Practice Principles” below:
TSH Biopharm’s 5th session of Board of Directors is set up with seven directors, three of which are independent directors. According to the Company’s policy on diversity, the members are experts of industrial, academic and medical areas, covering finance, accounting and other professional fields. They are equipped with the knowledge, skills and competencies to perform their duties,
Please refer to the following table for the diversity of the Board members:
|Core Items||Nationality||Gender||Operation management||Leadership decision||Industry knowledge||Finance Accounting||Law|
|Independent director||Wang, Chih-Li||Taiwan||Male||V||V|
|Independent director||Chen, Rwei-Syun||Taiwan||Female||V||V||V||V|
|Independent director||Huang, Yaw-Bin||Taiwan||Female||V||V|
The current Board of Directors consists of seven directors, with an average age of 64.28 years. One director aged between 36-40, one director aged between 56-60, two directors aged between 61-65, one director aged between 71-75 and two directors aged between 76-80.
No board member is an employee of the Company.
There are two female directors currently, accounting for 28.5% of the board membership. The Company aims to have 28% female directors to serve on the Board.
There are three independent directors, accounting for 42.9% of total members.
Two independent directors have served on the Board with their second term of office. All three independent directors’ tenure is below 3 terms.
TSH values diversity in its board members. The goals for directors possessing background in biotech industry and in accounting are 29% and 14%, respectively. The Company has 57% of directors with biotech background and 28.6% of directors with accounting background now.
Besides chairman and general manager, the Company also has directors for different functions. Due to sustainable development, the Company cultivates key talents for important management in various fields.
The Company has established the Talent Development Program since 2012 in order to cultivate a leader with three professional functions, including sales and marketing, research and development and management. Furthermore, the Company has constantly developed talents of the core team based on strategic positioning and has cultivated successor from each department in phases through Empower Leadership Program since 2022.